Snail and Slug mediate tamoxifen resistance in breast cancer cells through activation of EGFR-ERK independent of epithelial-mesenchymal transition.
暂无分享,去创建一个
T. Zhu | G. Ge | Q. Xiao | Q. Liu | Rui Zhang | Keshuo Ding | Yan Jiang | Xiaotong Zhao | Fei Yu
[1] Y Pawitan,et al. Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer , 2013, Oncogene.
[2] E. Martin,et al. Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration , 2012, Breast Cancer Research.
[3] A. Hill,et al. Metastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1. , 2012, Cancer research.
[4] P. V. van Diest,et al. Twist contributes to hormone resistance in breast cancer by down-regulating estrogen receptor alpha , 2011, Oncogene.
[5] U. Gündüz,et al. Drug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression pattern. , 2011, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[6] Hoo-Kyun Choi,et al. Involvement of Pin1 induction in epithelial–mesenchymal transition of tamoxifen‐resistant breast cancer cells , 2009, Cancer science.
[7] Robert L. Sutherland,et al. Biological determinants of endocrine resistance in breast cancer , 2009, Nature Reviews Cancer.
[8] Ben S. Wittner,et al. Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor , 2009, Proceedings of the National Academy of Sciences.
[9] R. Nicholson,et al. Tamoxifen resistance in MCF7 cells promotes EMT‐like behaviour and involves modulation of β‐catenin phosphorylation , 2006, International journal of cancer.